Good morning, folks! This is my last edition of Morning Rounds. Starting Monday, Shraddha Chakradhar will get you ahead of the day's news. There's a note from me at the end of this newsletter — but first, here's what you need to know about health and medicine today.

Inside STAT: States regroup on drug pricing efforts after a setback in Maryland

Last month, a Maryland effort to lower drug prices suffered another legal setback — and the news has state legislatures across the country re-examining their own approaches. Maryland’s law would have banned generic drug makers from hiking prices to a degree the state considers “unconscionable.” But an appeals court ruled it unconstitutional, and the Supreme Court doomed the law by declining to hear the case last month. STAT spoke with experts and state lawmakers who agreed the ruling doesn’t spell trouble for future drug pricing bills, but will force lawmakers to rethink their tactics. STAT’s Lev Facher has the story here.